TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+16.47%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$1.4B
AUM Growth
+$418M
(+43%)
Cap. Flow
+$310M
Cap. Flow
% of AUM
22.12%
Top 10 Holdings %
Top 10 Hldgs %
35.88%
Holding
163
New
35
Increased
43
Reduced
14
Closed
8
Top Buys
| 1 |
Aurinia Pharmaceuticals
AUPH
|
$32.6M |
| 2 |
BioNTech
BNTX
|
$32.1M |
| 3 |
Relay Therapeutics
RLAY
|
$25.3M |
| 4 |
ITOS
iTeos Therapeutics
ITOS
|
$24.6M |
| 5 |
Immunocore
IMCR
|
$21.8M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$24.4M |
| 2 |
Dynavax Technologies
DVAX
|
$6.68M |
| 3 |
Beam Therapeutics
BEAM
|
$2.45M |
| 4 |
Inhibrx
INBX
|
$2.37M |
| 5 |
CRISPR Therapeutics
CRSP
|
$2.35M |
Sector Composition
| 1 | Healthcare | 95.59% |
| 2 | Technology | 1.47% |
| 3 | Communication Services | 1.22% |
| 4 | Real Estate | 0.34% |
| 5 | Financials | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Alexandria Real Estate Equities
ARE
$13.9B
| $4.75M | 0.34% |
40,000
| – | – |
|
77
Iovance Biotherapeutics
IOVA
$800M
| $4.7M | 0.34% |
500,000
| – | – |
|
|
ALMS
78
Alumis Inc. Common Stock
ALMS
$483M
| $4.56M | 0.33% |
+426,594
| New | +$4.56M |
|
79
Seer Inc
SEER
$114M
| $4.53M | 0.32% |
2,300,000
| – | – |
|
80
Arvinas
ARVN
$580M
| $4.43M | 0.32% |
180,000
| – | – |
|
|
81
Beam Therapeutics
BEAM
$1.9B
| $4.17M | 0.3% |
170,000
-100,000
| -37% | -$2.45M |
|
82
Sanofi
SNY
$122B
| $4.03M | 0.29% |
+70,000
| New | +$4.03M |
|
83
C4 Therapeutics
CCCC
$182M
| $3.99M | 0.29% |
700,000
+500,000
| +250% | +$2.85M |
|
84
Heron Therapeutics
HRTX
$204M
| $3.68M | 0.26% |
1,850,000
| – | – |
|
|
CYBN
85
Cybin
CYBN
$142M
| $3.56M | 0.25% |
+400,000
| New | +$3.56M |
|
86
Tyra Biosciences
TYRA
$657M
| $3.53M | 0.25% |
150,000
+107,777
| +255% | +$2.53M |
|
87
Compass Therapeutics
CMPX
$466M
| $3.34M | 0.24% |
+1,812,995
| New | +$3.34M |
|
88
Nkarta
NKTX
$149M
| $2.94M | 0.21% |
650,000
+100,000
| +18% | +$452K |
|
|
ELEV
89
DELISTED
Elevation Oncology
ELEV
| $2.86M | 0.2% |
4,760,000
+1,700,000
| +56% | +$1.02M |
|
90
Kezar Life Sciences
KZR
$28.5M
| $2.81M | 0.2% |
+364,030
| New | +$2.81M |
|
91
Bolt Biotherapeutics
BOLT
$9.29M
| $2.47M | 0.18% |
190,639
| – | – |
|
92
Fate Therapeutics
FATE
$115M
| $2.45M | 0.18% |
700,000
| – | – |
|
93
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $2.44M | 0.17% |
2,350,000
+1,300,000
| +124% | +$1.35M |
|
94
Genmab
GMAB
$16.7B
| $2.44M | 0.17% |
100,000
| – | – |
|
|
TECX
95
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
| $2.4M | 0.17% |
79,166
| – | – |
|
|
SWTX
96
DELISTED
SpringWorks Therapeutics
SWTX
| $2.38M | 0.17% |
+74,265
| New | +$2.38M |
|
97
TG Therapeutics
TGTX
$5.03B
| $2.34M | 0.17% |
100,000
| – | – |
|
98
Theravance Biopharma
TBPH
$692M
| $2.12M | 0.15% |
+262,896
| New | +$2.12M |
|
99
Kura Oncology
KURA
$732M
| $1.95M | 0.14% |
100,000
| – | – |
|
100
Century Therapeutics
IPSC
$40.4M
| $1.54M | 0.11% |
900,000
| – | – |
|